Table 2 UBE2C IHC level and bio-clinical parameters
From: Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
Variable | UBE2C IHC<11% ( n =40) | UBE2C IHC⩾11% ( n =52) | P -value |
---|---|---|---|
Age | 50.4 (8.5)a | 54.5 (10.4) | 0.030 |
Histology | |||
IDC− | 6 | 12 | |
IDC+ | 34 | 40 | 0.301 |
Histological size | |||
Raw value | 25 (14) | 30 (14) | 0.116 |
<20 mm | 14 | 9 | |
⩾20 mm | 26 | 43 | 0.088 |
SBR | |||
I | 16 | 3 | |
II | 18 | 23 | |
III | 5 | 26 | <0.001 |
Positive nodes | |||
⩽3 | 34 | 32 | |
>3 | 6 | 20 | 0.019 |
ER | |||
− | 2 | 11 | |
+ | 38 | 41 | 0.035 |
PR | |||
− | 7 | 17 | |
+ | 33 | 35 | 0.150 |
Hormonotherapy | |||
− | 6 | 12 | |
+ | 34 | 40 | 0.430 |
IHC Ki-67 | |||
<11% | 25 | 2 | |
⩾11% | 15 | 50 | <0.001 |
NPI | |||
1 | 7 | 0 | |
2 | 27 | 24 | |
3 | 6 | 28 | <0.001 |